RFCA
NVO

R&F Capital Advisors’s Novo Nordisk NVO Stock Holding History

R&F Capital Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$799K Buy
+46,608
New +$812K 0.21% 137

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

R&F Capital Advisors's NVO Position: Q1 2017 in Review

R&F Capital Advisors opened a new position in Novo Nordisk (NVO) in Q1 2017: 46,608 shares worth $799K. The stake represents 0.21% of the portfolio and ranks #137 among its holdings.

463 funds tracked by Wall St. Rank hold NVO as of Q1 2017.

  • R&F Capital Advisors held 46,608 shares of Novo Nordisk worth $799K as of Q1 2017.
  • Novo Nordisk was a new R&F Capital Advisors position in Q1 2017.
  • Novo Nordisk made up 0.21% of R&F Capital Advisors's portfolio in Q1 2017, its #137 holding.
  • 463 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2017.

Based on R&F Capital Advisors's 13F filing for Q1 2017, filed 15 May 2017.